More than two percent of adult patients now take a GLP-1 drug to treat overweight or obesity, according to newly released FAIR Health data, with much of the increase occurring over the past few years.
More than two percent of adult patients now take a GLP-1 drug to treat overweight or obesity, according to newly released FAIR Health data, with much of the increase occurring over the past few years.